Approval · Notice of Compliance 33710 · 2024
AMOXICILLIN: Notice of Compliance 33710
Issued July 24, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33710
- Date
- July 24, 2024
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Administrative: Update to labelling (to match Licensor). New package insert
- Canadian reference product
- APO-AMOXI (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | Not yet assigned | — |
Medicinal ingredients
- AMOXICILLIN 500 MG per CAP